Dáil Éireann Debate, Tuesday - 26 May 2026
1223. Deputy Ken O'Flynn asked the Minister for Health if the HSE has assessed the clinical impact of reimbursement delays for patients with progressive neurological conditions where irreversible deterioration may occur during the assessment process. [39068/26]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines and medical devices; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
